Billions of PBMC can reliably be collected by leukapheresis regardless of a patient's tumor type, containing not only CD4+ and CD8+ T-cells, but also monocytes which can be differentiated into professional antigen (Ag)-presenting dendritic cells (DCs) [19–21]. The gene discussed is CD4; the disease is neoplasm.